Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis-Reference-Cited by-同舟云学术

Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis

Published:2021-09-07 Issue:6 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Napolitano Maddalena¹^ORCID,Maffei Marianna²,Patruno Cataldo³,Leone Carlo Antonio²,Di Guida Adriana⁴^ORCID,Potestio Luca⁴,Scalvenzi Massimiliano⁴,Fabbrocini Gabriella⁴^ORCID

Affiliation:

1. Department of Medicine and Health Sciences Vincenzo Tiberio University of Molise Campobasso Italy

2. Otolaryngology Head and Neck Surgery Unit AORN Ospedali dei Colli Naples Italy

3. Department of Health Sciences University Magna Graecia of Catanzaro Catanzaro Italy

4. Section of Dermatology, Department of Clinical Medicine and Surgery University of Naples Federico II Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15120

Reference11 articles.

1. Treatment of Atopic Dermatitis with Biologic Drugs

2. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

3. Dupilumab with concomitant topical corticosteroids in adult patients with AD who are not adequately controlled with or are intolerant to ciclosporin A, or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase 3 clinical trial (LIBERTY AD CAFÉ);Bruin D;Br J Dermatol,2018

4. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study

5. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive analysis on the safety of two biologics dupilumab and omalizumab;Frontiers in Medicine;2024-08-08

2. Tralokinumab for the Treatment of Adult Atopic Dermatitis in Special Populations;Journal of Asthma and Allergy;2024-08

3. Interplay of cytokines in the pathophysiology of atopic dermatitis: insights from Murin models and human;Frontiers in Medicine;2024-03-25

4. The Past, the Present and the Future of Teledermatology: A Narrative Review;Clinical, Cosmetic and Investigational Dermatology;2024-03

5. Considerations for managing elderly patients with atopic dermatitis;Expert Review of Clinical Immunology;2024-01-09